| Financial Year |
March 31 2023 |
| Monetary Funds |
926,336,241.84 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
16,899,284.32 |
| Accounts Receivable |
575,924,203.06 |
| Advances to Suppliers |
41,391,067.19 |
| Other Receivables |
10,263,503.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
576,607,625.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,029,801.49 |
| Total Current Assets |
2,341,669,250.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
19,556,722.62 |
| Investment Properties |
-- |
| Fixed Assetes |
2,336,016,518.57 |
| Under-construction Projects |
106,885,308.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
466,233,521.76 |
| R&D expenses |
369,105,172.10 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,726,709.78 |
| Deferred Income Tax Assets |
51,077,793.84 |
| Other Non-Current Assets |
43,917,758.14 |
| Sub-Total of Non-Current Assets |
3,545,550,099.54 |
| Total Assets |
5,887,219,350.40 |
| Short-Term Loans |
242,886,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
140,767,074.20 |
| Accounts Payable |
575,949,703.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
132,432,615.38 |
| Taxes Payable |
34,459,814.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
299,058,342.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
150,990,712.26 |
| Other Current Liabilities |
2,790,796.70 |
| Sub-Total of Current Liabilities |
1,620,823,694.48 |
| Long-term Loans |
345,606,526.52 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
125,976,476.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
538,413,505.40 |
| Total Liabilities |
2,159,237,199.88 |
| Paid-In Capital(Or Share Stock) |
387,410,987.00 |
| Capital Surplus |
2,402,591,152.93 |
| Surplus Reserve |
115,815,925.36 |
| LESS:Treasury Stock |
56,936,040.00 |
| Undistributed Profits |
784,756,345.58 |
| Minority Stockholder's Interest |
56,709,504.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,671,272,645.90 |
| Owner's Equity（Stockholder's Equity） |
3,727,982,150.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,887,219,350.40 |
